Bioequivalence and Bioavailability Forum 09:04 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

In vitro Bioequivalence for suspension ophthalmic [Regulatives / Guidelines]

posted by weidson - Brazil, 2018-04-09 20:40  - Posting: # 18658
Views: 723

Dear All,

Has anyone in this group ever performed an in vitro bioequivalence study with an ophthalmic suspension that was guided by the Guidance on Dexamethasone / tobramycin (reviewed June 2012, June 2013 and June 2016)? If yes, what is the acceptance criterion for bioequivalence? In the draft nothing is mentioned for the range of acceptance of the mortality rate of the microorganisms.

https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm308032.pdf

Thanks vary much.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,768 posts in 3,999 threads, 1,255 registered users;
online 24 (0 registered, 24 guests [including 17 identified bots]).

It is not so much that I have confidence in scientists being right,
but that I have so much in nonscientists being wrong.    Isaac Asimov

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed